Cas:92886-86-7 tert-butyldiphenylsilyl triflate) manufacturer & supplier

Chemical Name:tert-butyldiphenylsilyl triflate)

CAS.NO:92886-86-7

Synonyms:tert-Butyl(diphenyl)silyl trifluoromethanesulfonate;tert-butyldiphenylsilyl trifgluormethanesulfonate;Methanesulfonic acid, 1,1,1-trifluoro-, (1,1-dimethylethyl)diphenylsilyl ester;TBDPS triflate;(2-Methyl-2-propanyl)(diphenyl)silyl trifluoromethanesulfonate;tBuPh2SiOTf;tert-butyldiphenylsilyl trifluoromethanesulfonate;PC7942;tert-Butyldiphenylsilyl Triflate

Molecular Formula:C₁₇H₁₉F₃O₃SSi

Molecular Weight:388.477

HS Code:2931900090

Physical and Chemical Properties:

Melting point:N/A

Boiling point:372.0±42.0 °C at 760 mmHg

Density:1.3±0.1 g/cm3

Index of Refraction:1.522

PSA:51.75000

Exact Mass:388.077637

LogP:7.27

Material Safety Information (Applicable for Hazard Chemicals)

RIDADR:UN 1760

Packing Group:III

Contact us for information like tert-Butyl(diphenyl)silyl trifluoromethanesulfonate chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,tert-Butyldiphenylsilyl Triflate physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,PC7942 Use and application,tert-Butyldiphenylsilyl Triflate technical grade,usp/ep/jp grade.

Related News: Covington has handled dozens of cases for Lilly over the past 20 years, according to the Westlaw database of legal cases and press releases, including intellectual property matters, personal injury lawsuits and class actions. tert-butyldiphenylsilyl triflate) manufacturer Madeleine Roche, Associate Pharmaceutical Analyst at GlobalData, comments: ��Within the top 20 global companies that spent the most on R&D in 2018, the top spender �C despite having the second smallest annual revenue of the group at $15.28 billion �C is Celgene, whose R&D spend was equal to 37% of its annual revenue. tert-butyldiphenylsilyl triflate) supplier Madeleine Roche, Associate Pharmaceutical Analyst at GlobalData, comments: ��Within the top 20 global companies that spent the most on R&D in 2018, the top spender �C despite having the second smallest annual revenue of the group at $15.28 billion �C is Celgene, whose R&D spend was equal to 37% of its annual revenue. tert-butyldiphenylsilyl triflate) vendor Therefore, the growth of the global pharmaceutical market has greatly affected the development of the entire intermediate and API industry. tert-butyldiphenylsilyl triflate) factory The downstream industry of the pharmaceutical intermediate industry is mainly the production of APIs, and the relationship between APIs and preparations is in the upstream and downstream industry chain. The consumer demand for downstream preparations will directly affect the demand for APIs.